{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:36:15Z","timestamp":1788197775420,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaacap.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jaac.2018.07.891","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T16:43:03Z","timestamp":1539708183000},"page":"167-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Meta-Review: Network Meta-Analyses in Child and Adolescent Psychiatry"],"prefix":"10.1016","volume":"58","author":[{"given":"Samuele","family":"Cortese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneka","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2018.07.891_bib1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.euroneuro.2015.06.009","article-title":"Unmet needs in paediatric psychopharmacology: present scenario and future perspectives","volume":"25","author":"Persico","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2018.07.891_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/eb-2015-102275","article-title":"Approaches for synthesising complex mental health interventions in meta-analysis","volume":"19","author":"Caldwell","year":"2016","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.jaac.2018.07.891_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaac.2018.07.891_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/M15-2367","article-title":"Network meta-analysis for clinical practice guidelines: a case study on first-line medical therapies for primary open-angle glaucoma","volume":"164","author":"Rouse","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaac.2018.07.891_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/eb-2015-102088","article-title":"A\u00a0primer on network meta-analysis with emphasis on mental health","volume":"18","author":"Mavridis","year":"2015","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.jaac.2018.07.891_bib6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2018.07.891_bib7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2018.07.891_bib8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2018.07.891_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2018.07.891_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib11","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2017.15006","article-title":"Comparisons of interventions for preventing falls in older adults: a systematic review and meta-analysis","volume":"318","author":"Tricco","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2018.07.891_bib12","doi-asserted-by":"crossref","first-page":"e013967","DOI":"10.1136\/bmjopen-2016-013967","article-title":"Comparative efficacy and tolerability of pharmacological interventions for attention-deficit\/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis","volume":"7","author":"Cortese","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaac.2018.07.891_bib13","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.jaac.2018.07.891_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-148-7-200804010-00011","article-title":"Exploring the geometry of treatment networks","volume":"148","author":"Salanti","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaac.2018.07.891_bib15","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1017\/S003329171700349X","article-title":"Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis","volume":"48","author":"Cipriani","year":"2018","journal-title":"Psychol Med"},{"key":"10.1016\/j.jaac.2018.07.891_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaac.2018.07.891_bib17","doi-asserted-by":"crossref","unstructured":"Chaimani A, Salanti G, Leucht S, Geddes JR, Cipriani A. Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article [published online ahead of print July 24, 2017]. Evid Based Ment Health. https:\/\/doi.org\/10.1136\/eb-2017-102753.","DOI":"10.1136\/eb-2017-102753"},{"key":"10.1016\/j.jaac.2018.07.891_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jclinepi.2008.10.001","article-title":"A\u00a0case study of multiple-treatments meta-analysis demonstrates that covariates should be considered","volume":"62","author":"Salanti","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaac.2018.07.891_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1017\/S2045796011000084","article-title":"What are evidence-based treatment recommendations?","volume":"20","author":"Barbui","year":"2011","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.jaac.2018.07.891_bib20","doi-asserted-by":"crossref","first-page":"k585","DOI":"10.1136\/bmj.k585","article-title":"Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study","volume":"360","author":"Nikolakopoulou","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jaac.2018.07.891_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jclinepi.2007.06.006","article-title":"Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions","volume":"61","author":"Song","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaac.2018.07.891_bib22","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jaac.2018.07.891_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaac.2018.07.891_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaac.2018.07.891_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13643-015-0005-7","article-title":"The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials","volume":"4","author":"Catala-Lopez","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.jaac.2018.07.891_bib26","doi-asserted-by":"crossref","first-page":"e0180355","DOI":"10.1371\/journal.pone.0180355","article-title":"The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials","volume":"12","author":"Catala-Lopez","year":"2017","journal-title":"PLoS One"},{"issue":"suppl 1","key":"10.1016\/j.jaac.2018.07.891_bib27","first-page":"S166","article-title":"Systematic literature review and mixed treatment comparison of guanfacine extended release (GXR) versus other pharmacotherapies in children and adolescents with attention deficit\/hyperactivity disorder (ADHD). )","volume":"1","author":"Joseph","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib28","doi-asserted-by":"crossref","first-page":"A454","DOI":"10.1016\/j.jval.2014.08.1238","article-title":"Systematic literature review and mixed treatment comparison of Gxr versus other treatments in children and adolescents with attention deficit hyperactivity disorder (ADHD)","volume":"17","author":"Joseph","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.jaac.2018.07.891_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00787-017-0962-6","article-title":"Comparative efficacy and safety of attention-deficit\/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison","volume":"26","author":"Joseph","year":"2017","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib30","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1007\/s12035-016-0179-6","article-title":"An evaluation on the efficacy and safety of treatments for attention deficit hyperactivity disorder in children and adolescents: a comparison of multiple treatments","volume":"54","author":"Li","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jaac.2018.07.891_bib31","doi-asserted-by":"crossref","first-page":"A521","DOI":"10.1016\/j.jval.2016.09.1017","article-title":"A\u00a0network meta-analysis of atomoxetine, methylphenidate, lisdexamfetamine, and bupropion for the treatment of attention deficit hyperactivity disorder in children and adolescents","volume":"19","author":"Locatelli","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jaac.2018.07.891_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fpsyt.2017.00229","article-title":"Efficacy and tolerability of different interventions in children and adolescents with attention deficit hyperactivity disorder","volume":"8","author":"Luan","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1185\/03007995.2014.904772","article-title":"Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine","volume":"30","author":"Roskell","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaac.2018.07.891_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/schbul\/sbx139","article-title":"Negative symptom interventions in youth at risk of psychosis: a systematic review and network meta-analysis","volume":"44","author":"Devoe","year":"2018","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jaac.2018.07.891_bib35","doi-asserted-by":"crossref","first-page":"A115","DOI":"10.1016\/j.jval.2015.03.679","article-title":"Antipsychotics for treatment of pediatric schizophrenia: a systematic review and network meta-analysis of symptom control, weight gain and discontinuation due to adverse events","volume":"18","author":"Harvey","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.jaac.2018.07.891_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40263-015-0308-1","article-title":"A\u00a0systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia","volume":"30","author":"Harvey","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaac.2018.07.891_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.euroneuro.2018.03.008","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: a network meta-analysis","volume":"28","author":"Krause","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2018.07.891_bib38","doi-asserted-by":"crossref","first-page":"e005708","DOI":"10.1136\/bmjopen-2014-005708","article-title":"Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials","volume":"4","author":"Pagsberg","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaac.2018.07.891_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaac.2016.12.013","article-title":"Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis","volume":"56","author":"Pagsberg","year":"2017","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40263-015-0308-1","article-title":"A systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia","volume":"30","author":"Harvey","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaac.2018.07.891_bib41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2018.07.891_bib42","doi-asserted-by":"crossref","first-page":"e008572","DOI":"10.1136\/bmjopen-2015-008572","article-title":"Comparative efficacy and acceptability of psychotherapies for acute anxiety disorders in children and adolescents: study protocol for a network meta-analysis","volume":"5","author":"Zhang","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaac.2018.07.891_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/wps.20217","article-title":"Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: a systematic review and network meta-analysis","volume":"14","author":"Zhou","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib44","doi-asserted-by":"crossref","first-page":"e007768","DOI":"10.1136\/bmjopen-2015-007768","article-title":"Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis","volume":"5","author":"Zhou","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaac.2018.07.891_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1185\/03007990903416853","article-title":"Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: a mixed treatment comparison meta-analysis","volume":"26","author":"Uthman","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaac.2018.07.891_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamapediatrics.2017.3036","article-title":"Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: a systematic review and meta-analysis","volume":"171","author":"Wang","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaac.2018.07.891_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20430","article-title":"A\u00a0systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children\/adolescents and adults","volume":"20","author":"Skapinakis","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaac.2018.07.891_bib48","series-title":"AHRQ Comparative Effectiveness Reviews","author":"Epstein","year":"2015"},{"key":"10.1016\/j.jaac.2018.07.891_bib49","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40273-013-0091-0","article-title":"Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: a NICE single technology appraisal","volume":"31","author":"Uttley","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaac.2018.07.891_bib50","series-title":"AHRQ Comparative Effectiveness Reviews","author":"Pillay","year":"2017"},{"key":"10.1016\/j.jaac.2018.07.891_bib51","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00406-016-0715-4","article-title":"Network meta-analyses should be the highest level of evidence in treatment guidelines","volume":"266","author":"Leucht","year":"2016","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jaac.2018.07.891_bib52","unstructured":"National Institute for Health and Care Excellence (NICE). https:\/\/www.nice.org.uk\/guidance\/ng87. Accessed June 15,\u00a02018."},{"key":"10.1016\/j.jaac.2018.07.891_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0269881113519509","article-title":"Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology","volume":"28","author":"Bolea-Alamanac","year":"2014","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.07.891_bib54","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib55","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/appi.ajp.2017.16091059","article-title":"Antidepressant efficacy for depression in children and adolescents: industry- and NIMH-funded studies","volume":"174","author":"Walkup","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.chi.0000246070.23695.06","article-title":"Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders","volume":"46","author":"Connolly","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","article-title":"Practice parameter for the assessment and treatment of children and adolescents with\u00a0obsessive-compulsive disorder","volume":"51","year":"2012","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib58","unstructured":"National Institute for Health and Clinical Excellence (NICE). ADHD guidelines. https:\/\/www.nice.org.uk\/guidance\/cg155. Accessed June 15,\u00a02018."},{"key":"10.1016\/j.jaac.2018.07.891_bib59","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/0706743717720197","article-title":"Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth","volume":"62","author":"Abidi","year":"2017","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib60","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaac.2013.02.008","article-title":"Practice parameter for the assessment and treatment of children and adolescents with schizophrenia","volume":"52","author":"McClellan","year":"2013","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.07.891_bib61","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A\u00a0GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jaac.2018.07.891_bib62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000489227","article-title":"Cognitive-behavioral analysis system of psychotherapy, drug, or their combination for persistent depressive disorder: personalizing the treatment choice using individual participant data network metaregression","volume":"87","author":"Furukawa","year":"2018","journal-title":"Psychother Psychosom"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856718318793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856718318793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T20:36:02Z","timestamp":1717274162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856718318793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0890856718318793"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2018.07.891","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Review: Network Meta-Analyses in Child and Adolescent Psychiatry","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2018.07.891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92018 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}